72 A case report of a 54-year-old male patient with pre-existing hypertension, hyperlipidemia, and obesity who was tested positive for COVID-19 11 days prior to admission to Holy Family Hospital in Massachusetts showed that combination therapy of hydroxychloroquine and N-acetylcysteine led to a progressive clinical improvement and a decrease in inflammatory markers for inflammation, for instance, C-reactive protein and lactic acid
Berberine has been shown to reduce weight, body mass index, and waist circumference
The concentrated purified protein was aliquoted and stored at -80 C
Liu, P., Wang, Z
Sbaraglini ML, Molinuevo MS, Sedlinsky C, Schurman L, McCarthy AD
Glucagon-like peptide-1 (GLP-1) receptor agonists were originally developed to treat people with type 2 diabetes, entering clinical use in the mid-2000s